MedTrace Logo

Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F

NCT04765345 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 44

Last updated 2026-02-04

No results posted yet for this study

Summary

The overall goal of this project, co-funded by the Foundation Fighting Blindness and the USHER 1F Collaborative is to characterize the natural history of disease progression in patients with PCDH15 mutations in order to accelerate the development of outcome measures for clinical trials.

Conditions

Sponsors & Collaborators

  • Usher 1F Collaborative

    collaborator UNKNOWN

  • Marjorie C. Adams Foundation

    collaborator UNKNOWN

  • Foundation Fighting Blindness

    collaborator OTHER

  • Jaeb Center for Health Research

    lead OTHER

Principal Investigators

  • Katarina Stingl, MD · University Hospital Tuebingen

Eligibility

Min Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-08
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • United States
  • Canada
  • France
  • Germany
  • Israel
  • Netherlands
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04765345 on ClinicalTrials.gov